Modular Autoinjector Platform Design & Engineering

The contract seeks the design and engineering of a modular, ruggedized autoinjector platform capable of delivering multiple pharmaceutical formulations with minimal redesign across variants, ensuring flexibility and scalability for diverse medical applications. The platform must be engineered to withstand harsh environmental conditions while maintaining precise dosing accuracy, reliability, and ease of use in field or deployable settings, with a focus on reducing development time and cost between product iterations. Performance is expected to occur in Gunpowder, Maryland, with a response deadline of August 7, 2026, and the work is classified as a subcontract under NAICS code 334510, indicating a focus on medical equipment and supplies manufacturing. The contracting agency is the Department of Defense through W6QK Acc-Apg, signaling a defense or military medical procurement context where robust, field-ready devices are critical for operational readiness and personnel health. The emphasis on modularity and ruggedization implies stringent performance and durability standards aligned with DoD operational requirements.